The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Ajinomoto Bio-Pharma Services
Ajinomoto Bio-Pharma Services has announced the launch of AJILITY™, a flexible and agile drug product manufacturing platform.
read more
The FDA has taken an additional step in harnessing real-world data to help inform the agency’s overall response to the COVID-19 public health ...
read more
Sumitovant Biopharma announced Urovant Sciences has entered into a three-year distribution agreement to support the commercialization of vibegron.
read more
Evelo Biosciences announced EDP1815 will be included in the TACTIC-E clinical trial.
read more
The FDA approved a new fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase–zzxf for subcutaneous injection.
read more
The FDA has issued a guidance for industry entitled, “Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency.”
read more
Valneva and Bavarian Nordic have signed a binding term sheet to establish a partnership for the marketing and distribution of their commercial ...
read more
Ampio Pharmaceuticals is developing therapies for patients infected with the SARS-CoV-2 virus (COVID-19).
read more
The FDA has approved Crysvita injection to treat tumor-induced osteomalacia.
read more
Arch Biopartners announced the FDA has granted permission to proceed with a trial in the U.S. for Metablok to prevent acute lung and kidney injury for...
read more
Novartis announced the FDA has approved Cosentyx for active non-radiographic axial spondyloarthritis.
read more
The FDA has granted accelerated approval to lurbinectedin for adult patients with metastatic small cell lung cancer.
read more
PTC announced the FDA has authorized the initiation of a trial to investigate PTC299 as a potential treatment for COVID-19.
read more
Sagimet Biosciences announced positive results from trial of FASN inhibitor TVB-2640 as a potential treatment for NASH.
read more
The FDA has approved Lyumjev, Lilly's new rapid-acting insulin indicated to improve glycemic control in adults with type 1 and type 2 diabetes.
read more